RIDER : Breast MRI (5 subjects)
|
|
0
|
247
|
January 9, 2021
|
Quantitative Imaging Network : Sarcoma (15 subjects)
|
|
0
|
193
|
January 5, 2021
|
Quantitative Imaging Network : Head and Neck (279 subjects)
|
|
0
|
222
|
January 5, 2021
|
Quantitative Imaging Network : Breast 02 (13 subjects)
|
|
0
|
196
|
January 5, 2021
|
Quantitative Imaging Network : Breast (67 subjects)
|
|
0
|
220
|
January 5, 2021
|
Quantitative Imaging Network : Breast DCE-MRI (10 subjects)
|
|
0
|
187
|
January 4, 2021
|
Non-Small Cell Lung Cancer : Cetuximab (490 subjects)
|
|
0
|
193
|
December 30, 2020
|
NRG-1308 (12 subjects)
|
|
0
|
199
|
December 30, 2020
|
NaF Prostate (9 subjects)
|
|
0
|
190
|
December 30, 2020
|
ISPY : Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and moLecular Analysis (222 subjects)
|
|
0
|
206
|
December 27, 2020
|
Positron Emission Tomography Pre- and Post-treatment Assessment for Locally Advanced Non-small Cell Lung Carcinoma (242 subjects)
|
|
0
|
184
|
December 10, 2020
|
Head and Neck Cetuximab (111 subjects)
|
|
0
|
196
|
December 20, 2020
|
Head and Neck Radiomics HN1 (137 subjects)
|
|
0
|
331
|
December 20, 2020
|
HNSCC : Head and neck squamous cell carcinoma (627 subjects)
|
|
0
|
236
|
December 20, 2020
|
HNSCC CT taken during pre-treatment, mid-treatment, and post-treatment (31 subjects)
|
|
0
|
188
|
December 20, 2020
|